Free Founding Tester Beta — live now · Free while the beta runs. No card, no subscription, no charge.
Aurygine
Operating knowledge

Capital

Is there anything worth raising against?

Raising is being considered, usually because cash is short or growth is wanted faster.

Signals to look for

  • raise
  • investor
  • funding
  • vc
  • round
  • pitch
  • dilution

Questions to answer

  • What specific thing would the money buy that cannot be earned?
  • What evidence exists that spending it works?
  • What does this type of investor require as proof, and is that different from what is held?
  • What happens if nothing is raised?

Evidence required before committing

  • {revenue} trend
  • retention
  • acquisition cost and payback
  • the plan the money funds
  • runway

Likely constraint

  • No proven use of funds
  • Evidence mismatched to the investor type approached

How the decision branches

  • If
    Acquisition economics are unproven
    Then
    Money buys a faster version of an unknown. Prove the channel first.
  • If
    Economics work and cash is the only limit
    Then
    Capital buys time, which is legitimate. Judge dilution against speed and probability, not ownership percentage alone.
  • If
    Different investor types are being approached with one story
    Then
    Adapt the evidence to what each actually underwrites.

What to test

Write the use of funds as three milestones with dates and the evidence behind each, then show it to two informed outsiders before any investor.

Read after 30 days.

What success looks like

  • Both outsiders can restate the plan accurately
  • Each milestone has evidence, not ambition

What means stop

  • The use of funds cannot be written concretely — the company is not ready to raise

Typical next move

  • The plan holds → Choose the capital type deliberately.
  • It does not → Fix the economics; raising will not fix them.

Who does the work

Aury can carry out: read company, prepare document, file memory, flag risk. Specialists involved: finance, strategy.

Your approval: Aurygine prepares material. It never contacts investors and never makes a capital commitment.

This needs financial review — get a qualified professional to look at your specifics before anything is signed or sent.

Where this stops being true

Applies where capital is genuinely available to this company.

Nothing here is investment advice. Securities offerings are regulated; take qualified financial and legal advice before approaching investors. Aurygine holds no benchmark for what investors in your market require.

Provenance

  • Sourced operator experience: Founder/operator case study analysed inside Aurygine — bootstrapped B2B software company, 2026
  • Aurygine synthesis: Aurygine synthesis across founder journeys

Confidence: low. Last reviewed 2026-08-25. Your company's own recorded results override this playbook whenever the two disagree.